Acorda $ACOR Therapeutics is Strong on a Midterm Basis, Shown in Charts and Graphs
Acorda (NASDAQ: ACOR) Therapeutics is Strong on a Midterm Basis, as Shown in the Charts and Graphs below. Important: Check the date of this report, and update the report if it is old. The data changes over time.
Long Term Trading Plans for ACOR
June 5, 2018, 5:49 pm ET
The technical Summary and associated Trading Plans for ACOR listed below will help you make important timing decisions for your trades. This data is based on our proprietary analysis for ACOR. In addition we offer Market Timing Models and Stock Filters in the links above which may increase the proficiency of the decisions you make.
ACOR - (Long) Support Plan
Buy over 24.05 target 29.09 stop loss @ 23.79.
The technical summary data tells us to buy ACOR near 24.05 with an upside target of 29.09. This data also tells us to set a stop loss @ 23.79 to protect against excessive loss in case the stock begins to move against the trade. 24.05 is the first level of support below 26.35 , and by rule, any test of support is a buy signal. In this case, support 24.05 is being tested, a buy signal would exist.
ACOR - (Short) Resistance Plan
Short under 29.09 target 24.05 stop loss @ 29.35
The technical summary data is suggesting a short of ACOR as it gets near 29.09 with a downside target of 24.05. We should have a stop loss in place at 29.35 though. 29.09 is the first level of resistance above 26.35, and by rule, any test of resistance is a short signal. In this case, if resistance 29.09 is being tested, a short signal would exist.